Top 7 China Health Insurance Companies 2025

China's health insurance system covers over 1.4 billion people through a multi-tier framework comprising basic social health insurance (urban employee and rural resident schemes), supplementary commercial health insurance, and critical illness insurance. The total health insurance market exceeded ¥8 trillion in 2024, with commercial health insurance premiums reaching ¥900+ billion. Major commercial health insurers are expanding coverage to include outpatient care, chronic disease management, innovative drug reimbursement, and integrated health management services, driven by government policy support and growing consumer demand for quality healthcare access.

TL;DR: China's ¥8T+ health insurance system covers 1.4B people, led by PICC Health (largest commercial health insurer, ¥900B+ premiums), China Life Health Insurance, Ping An Health, Taikang Life (critical illness leader), CPIC Health, New China Life Health, and Sunshine Insurance. Key trends: Huiminbao city-level supplementary insurance, integrated health management, innovative drug coverage, digital claims processing.

PICC Health Insurance

Premiums: ¥900B+ (2024)

PICC Health Insurance is China's largest commercial health insurance company by premium volume. A subsidiary of PICC Group (People's Insurance Company of China), it dominates the market with extensive coverage across urban employee supplementary medical insurance, rural cooperative medical insurance administration, and commercial health products. PICC Health also partners with local governments across 200+ cities to administer social health insurance funds and Huiminbao supplementary insurance programs.

China Life Health Insurance

Premiums: ¥600B+ (2024)

China Life Health Insurance is the health insurance arm of China Life Insurance, China's largest life insurer. The company offers a comprehensive range of health insurance products including critical illness insurance, medical expense reimbursement, outpatient coverage, and long-term care insurance. China Life Health leverages the parent company's massive distribution network of over 1 million agents to reach consumers nationwide, particularly in lower-tier cities and rural areas.

Ping An Health (Ping An Good Doctor)

Premiums: ¥200B+ (2024)

Ping An Health operates China's largest integrated health management platform, combining commercial health insurance with online medical consultation, hospital referral services, and chronic disease management. The company's Ping An Good Doctor platform has over 400 million registered users. Ping An Health pioneered the 'insurance + health management' model in China, using technology to reduce healthcare costs while improving outcomes for policyholders.

Taikang Life Insurance

Health premiums: ¥500B+ (2024)

Taikang Life Insurance is a major Chinese insurer with a strong health insurance portfolio, particularly in critical illness insurance which is China's fastest-growing insurance segment. The company has developed innovative products combining life insurance, critical illness coverage, and health management services. Taikang has invested heavily in healthcare infrastructure including hospitals,养老 communities (senior living), and rehabilitation centers to create an integrated health insurance ecosystem.

CPIC Health Insurance

Premiums: ¥300B+ (2024)

CPIC Health Insurance is the health insurance division of China Pacific Insurance (CPIC), one of China's top three insurance groups. The company offers a wide range of commercial health insurance products including supplementary medical insurance, critical illness insurance, and high-end medical insurance. CPIC Health has been expanding its Huiminbao city supplementary insurance business and investing in digital health insurance platforms for faster claims processing.

New China Life Health

Premiums: ¥250B+ (2024)

New China Life Health Insurance is the health insurance subsidiary of New China Life Insurance Company. The company provides critical illness insurance, medical expense insurance, and supplementary medical coverage. New China Life Health has been expanding its product portfolio to include innovative drug coverage, gene therapy reimbursement, and personalized health management services. The company serves over 50 million health insurance policyholders nationwide.

Sunshine Insurance Group

Health premiums: ¥150B+ (2024)

Sunshine Insurance Group offers health insurance products through its life and property & casualty subsidiaries. The company's health insurance portfolio includes critical illness coverage, medical reimbursement, accident medical insurance, and maternal/child health insurance. Sunshine has been actively developing digital-first health insurance products and partnering with technology platforms for distribution. The company listed on the Hong Kong Stock Exchange in 2022.

Comparison Table

CompanyTypePremiumsPolicyholdersInnovationDigitalGrowth
PICC HealthCommercial + Gov¥900B+500M+HuiminbaoStrongModerate
China Life HealthCommercial¥600B+300M+Critical illnessModerate15%+
Ping An HealthIntegrated¥200B+400M usersOnline doctorLeading20%+
Taikang LifeCommercial¥500B+200M+Health ecosystemModerate15%+
CPIC HealthCommercial¥300B+150M+HuiminbaoStrongModerate
New China LifeCommercial¥250B+50M+Drug coverageModerateModerate
Sunshine InsuranceCommercial¥150B+80M+Digital-firstGrowing15%+

Frequently Asked Questions

How does China's health insurance system work?

China's health insurance system has three tiers: (1) Basic social health insurance — covers 95%+ of the population through two schemes: Urban Employee Basic Medical Insurance (UEBMI, 400M+ enrolled, funded by employer/employee contributions) and Urban-Rural Resident Basic Medical Insurance (URRBMI, 900M+ enrolled, funded by individual premiums + government subsidies); (2) Critical Illness Insurance — supplementary coverage for major diseases, mandatory enrollment; (3) Commercial health insurance — voluntary private coverage for enhanced benefits. Average reimbursement rate is approximately 70% for employee insurance and 50-60% for resident insurance.

What is Huiminbao insurance?

Huiminbao (惠民保, 'people's welfare insurance') is a city-level supplementary commercial health insurance program launched across 200+ Chinese cities since 2020. It offers low-premium (typically ¥50-200/year), high-coverage supplementary medical insurance to all residents regardless of age or health status. Huiminbao covers expenses not reimbursed by basic social insurance including high-cost drugs, imported medical devices, and out-of-pocket hospital costs. Major insurers like PICC Health and CPIC Health partner with local governments to administer these programs.

How large is China's commercial health insurance market?

China's commercial health insurance market exceeded ¥900 billion in premium revenue in 2024, making it one of the world's largest health insurance markets by premium volume. The market has been growing at 15-25% annually over the past decade, driven by rising healthcare costs, growing middle-class demand for quality care, and government policy encouragement. Health insurance now accounts for approximately 25% of total life insurance premiums in China, up from 10% a decade ago.

What health insurance do Chinese companies provide employees?

Chinese companies with formal employment relationships must enroll employees in Urban Employee Basic Medical Insurance (UEBMI), funded by employer contributions (typically 8-10% of payroll) and employee deductions (typically 2% of salary). Many employers also provide supplementary commercial medical insurance as an employee benefit, covering: outpatient reimbursement above social insurance limits, inpatient daily allowances, critical illness supplementary coverage, and international/Europe/USA medical coverage for senior executives. Large tech companies like Alibaba, Tencent, and ByteDance offer premium commercial health benefits.

How does China's DRG payment reform affect health insurance?

China's DRG (Diagnosis Related Group) payment reform, being rolled out nationally since 2019, significantly impacts health insurance by standardizing hospital payments based on diagnosis categories rather than fee-for-service. This reform: (1) Controls healthcare cost growth by setting fixed payments per diagnosis; (2) Incentivizes hospitals to improve efficiency and reduce unnecessary treatments; (3) Shifts financial risk from insurers/patients to hospitals; (4) Creates demand for commercial supplementary insurance to cover cost-sharing gaps; (5) Drives commercial insurers to develop value-based insurance products aligned with DRG payment structures.